Chronic pain and fatigue in multiple osteochondroma and Ollier disease, a systematic review.

TL;DR

Chronic pain affects 54-95% of patients with multiple osteochondromas (a genetic bone tumor condition), with fatigue also emerging as a significant but understudied complaint. The evidence base remains weak, consisting mostly of case reports with no randomized controlled trials.

What the Study Found

Researchers conducted a systematic review of 63 studies involving 1,252 patients with multiple osteochondromas or Ollier disease (both rare genetic conditions causing multiple benign bone tumors). The goal was to synthesize what's known about chronic pain and fatigue in these populations, identify knowledge gaps, and guide future research priorities.

The prevalence of chronic pain varied substantially by age. In adults with multiple osteochondromas, chronic pain rates ranged from 80-95%. In children with the condition, prevalence was lower but still substantial at 54-64%. This wide range reflects heterogeneity in how pain was measured across studies: only 29 of 63 studies used standardized assessment methods for pain, and just 7 used standardized fatigue measures. The majority of included studies were case reports, which typically provide lower quality evidence than larger cohort designs. Notably, no randomized controlled trials examining pain or fatigue management in these conditions were identified.

Beyond prevalence data, the review documented that both pain and fatigue significantly impacted patients' daily functioning. Reported consequences included interference with activities of daily living, mood disturbances, sleep disruption, and reduced social and physical participation. The review identified multiple factors that modulated pain and fatigue intensity, though the specific nature of these relationships remains poorly characterized. Treatment approaches described in the literature included conservative "wait-and-see" strategies, surgical intervention, physiotherapy, and medication, but no systematic comparison of treatment effectiveness was possible given the evidence base limitations.

Ollier disease received minimal research attention: only 7 of 63 studies examined this variant, compared to 55 focused on multiple osteochondromas. For fatigue specifically, only 7 of 63 studies provided data. Among those studies reporting fatigue, patients consistently showed higher rates of severe fatigue or lower vitality scores compared to other patient groups or general population controls. This suggests fatigue is not simply an artifact of acute illness but a persistent feature of these conditions, though the mechanistic basis remains unclear.

What This Means for You

This systematic review identifies a critical evidence gap rather than providing definitive treatment guidance. If you or a family member has been diagnosed with multiple osteochondromas or Ollier disease, several points merit attention:

First, chronic pain and fatigue appear to be common features of these conditions, affecting quality of life in measurable ways. This differs from how they are sometimes portrayed in medical literature, where focus has centered on tumor growth and malignant transformation risk. Advocating for symptom management alongside tumor monitoring is evidence-aligned.

Second, current treatment evidence is anecdotal. The absence of rigorous comparative trials means clinicians and patients lack data on which interventions (surgery, physiotherapy, medications) provide the best outcomes. If pursuing treatment, asking your care team what outcomes they track and how your response compares to others they've treated is reasonable.

Third, the review highlights that fatigue, while common, remains understudied. Only 11% of included studies measured this outcome. If fatigue is significantly impacting your functioning, discussing this explicitly with your medical team is important, even if standardized protocols for management don't yet exist.

Non-pharmacological approaches like physiotherapy and movement breaks appear in case reports as part of multi-modal strategies, though rigorous evidence specific to these conditions is absent. Sleep disruption is documented as a consequence of pain and fatigue; optimizing sleep duration and sleep temperature are general interventions with broader evidence support that may offer ancillary benefit.

The review underscores that more research is needed: larger prospective cohort studies, standardized outcome measurement, and comparative effectiveness trials would substantially improve clinical decision-making for these rare conditions.

Study Details

Sources

Systematic review: "Chronic pain and fatigue in multiple osteochondroma and Ollier disease: a systematic review." BMC Musculoskeletal Disorders. PubMed: 42192362